This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Infusion Pumps: Technology And Market 2012-2022

NEW YORK, April 2, 2012 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Infusion Pumps: Technology and Market 2012-2022

Report Details

Our new report Infusion Pumps: Technology and Market 2012-2022 covers the trends in the infusion pumps market, a promising segment of the drug delivery sector. The traditional gravity controlled infusion pumps have been used extensively. The electronic infusion pumps have also been available in the market since long, but only beginning to see increased adoption. The use of infusion pumps is advantageous for the healthcare providers as well as the patients specifically for conditions such as diabetes, delivery of analgesics in cancer patients or post-surgery, delivery of chemotherapy drugs and enteral feeding in patients with feeding disorders. As the technology becomes more advanced, the infusion pumps are becoming smaller in size, wireless, and more convenient to use. Combined with the ability of the infusion pumps to deliver precisely measured dose are the right intervals, the infusion pumps allow the patients to carry out their normal activities, and reduce the hospital stay and visits. According to our latest pharma report - the global infusion pumps market will be worth $9.5bn by 2016.

Infusion Pumps: Technology and Market 2012-2022 report forecasts the size and value of leading national/regional markets: North America, Europe, Japan, India and China. For each of these, visiongain identifies prevailing trends and strategies that will steer this emerging technology over the forecast period. The use of infusion pumps is still more prevalent in the developed regions of North America and Europe, essentially owing to the fact that the infusion pump technology is expensive when compared to the competing technologies. The cost of insulin pumps is covered under Medicare in the US and through private insurance in Canada. However, there are huge opportunities for infusion pump manufacturers in the developing economies of India and China where the use of electronic infusion pumps is limited at present. The report discusses the future technological development that will make the infusion pumps more attractive to the patients and drive their adoption.

Infusion Pumps: Technology and Market 2012-2022 also examines the challenges facing the sector critically, including the high cost and safety issues. The report is developed through a comprehensive review of information sources, both primary and secondary. In our report you find sales forecasts, growth rates and market shares. You also receive qualitative analyses and a review of companies and leading products.

1 of 11

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.19 0.00%
FB $118.06 0.00%
GOOG $695.70 0.00%
TSLA $222.56 0.00%
YHOO $36.00 0.00%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs